Subcutaneous injection of insulin is widely accepted in diabetic patients, but it is invasive and thus has many disadvantages such as infections, hypoglycemia, peripheral hyperinsulinemia, and poor pharmacodynamic (9). The gene discussed is INS; the disease is Hyperinsulinemia.